Infect Chemother.  2011 Apr;43(2):206-209. 10.3947/ic.2011.43.2.206.

Guillain-Barre Syndrome in a Patient with Chemotherapy for HIV Related Burkitt's Lymphoma

• Lee HW
• Song SO
• Kang BD
• Dong SH
• Kim Y
• Park YH
• Lee HM
• Lee KS

• KMID: 1782363
• DOI: http://doi.org/10.3947/ic.2011.43.2.206

Abstract

Human immunodeficiency virus infection is not a common cause of Guillain-Barre syndrome. Guillain-Barre syndrome with cerebrospinal fluid pleocytosis has been associated with early human immunodeficiency virus (HIV) infection, occasionally as the presenting manifestation. We report a case of 73-year-old Korean malen with acute motor axonal variant of Guillain-Barre syndrome during chemotherapy for HIV- related Burkitt's lymphoma. This is the first report of Guillain-Barre syndrome occurringed within HIV infection in Korea.

Keyword

Guillain-Barre syndrome; Burkitt's lymphoma; HIV infection

MeSH Terms

Aged
Axons
Burkitt Lymphoma
Guillain-Barre Syndrome
HIV
HIV Infections
Humans
Korea
Leukocytosis

Figure

• 

  Figure 1 (A) Bone marrow smear showing lymphoblasts containing deeply basophilic cytoplasm and abundant lipid vacuoles in the cytoplasm (Wright stain, ×100). (B) Bone marrow biopsy showing characteristic "starry sky" appearance (H&E stain, ×1,000).

Reference

1. Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barré Syndrome. 1991. 1st ed. Philadelphia: F. A. Davis;43–54.

2. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, Asbury AK, Blaser MJ, McKhann GM. Guillain-Barré syndrome in northern China. Relationship to campylobacter jejuni infection and anti-glycolipid antibodies. Brain. 1995. 118:597–605.

3. Jacobs BC, Rothbarth PH, van der Meché FG, Herbrink P, Schmitz PI, de Klerk MA, van Doorn PA. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology. 1998. 51:1110–1115.

4. Visser LH, van der Meché FG, Meulstee J, Rothbarth PP, Jacobs BC, Schmitz PI, van Doorn PA. Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré study group. Neurology. 1996. 47:668–673.

5. Hagberg L, Malmvall BE, Svennerholm L, Alestig K, Norkrans G. Guillain-Barré syndrome as an early manifestation of HIV central nervous system infection. Scand J Infect Dis. 1986. 18:591–592.

6. Howlett WP, Vedeler CA, Nyland H, Aarli JA. Guillain-Barré syndrome in northern Tanzania: a comparison of epidemiological and clinical findings with western Norway. Acta Neurol Scand. 1996. 93:44–49.

7. Brannagan TH 3rd, Zhou Y. HIV-associated Guillain-Barré syndrome. J Neurol Sci. 2003. 208:39–42.

8. Pluda JM, Yarchoan R, Jaffe ES, Feuerstein IM, Solomon D, Steinberg SM, Wyvill KM, Raubitschek A, Katz D, Broder S. Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. Ann Intern Med. 1990. 113:276–282.

9. Dal Maso L, Rezza G, Zambon P, Tagliabue G, Crocetti E, Vercelli M, Zanetti R, Falcini F, Tonini G, Mangone L, De Lisi V, Ferretti S, Tumino R, Stanta G, Vitarelli S, Serraino D, Franceschi S. Cancer and AIDS Registry Linkage Study. Non-Hodgkin lymphoma among young adults with and without AIDS in Italy. Int J Cancer. 2001. 93:430–435.

10. Chadburn A, Cesarman E, Jagirdar J, Subar M, Mir RN, Knowles DM. CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer. 1993. 72:3078–3090.

11. Hughes RA, Hadden RD, Gregson NA, Smith KJ. Pathogenesis of Guillain-Barré syndrome. J Neuroimmunol. 1999. 100:74–97.

12. Wagner JC, Bromberg MB. HIV infection presenting with motor axonal variant of Guillain-Barré syndrome. J Clin Neuromuscul Dis. 2007. 9:303–305.

13. Fujiwara S, Oshika H, Motoki K, Kubo K, Ryujin Y, Shinozaki M, Hano T, Nishio I. Diabetic ketoacidosis associated with Guillain-Barré syndrome with autonomic dysfunction. Intern Med. 2000. 39:495–498.

14. Kumar S, Alexander M, Markandeyulu V, Gnanamuthu C. Guillain-Barre syndrome presenting in the anti-HIV seroconversion period. Neurol India. 2003. 51:559.

15. Pal PK. Clinical and electrophysiological studies in vincristine induced neuropathy. Electromyogr Clin Neurophysiol. 1999. 39:323–330.